<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04181281</url>
  </required_header>
  <id_info>
    <org_study_id>Renal CEUS against ASL-MRI</org_study_id>
    <nct_id>NCT04181281</nct_id>
  </id_info>
  <brief_title>Validation of Renal Perfusion CEUS Against MRI</brief_title>
  <official_title>Validation of Contrast Enhanced Ultrasound (CEUS) for the Assessment of Renal Perfusion Using Renal Magnetic Resonance Imaging (MRI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is establishing a new ultrasound technique to improve assessment of
      kidney blood flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Kidneys have an extremely high blood flow. A quarter of the blood that is pumped by the heart
      goes to the kidneys, and your entire blood volume passes through your kidneys forty times
      each day. Some of this blood flow is needed to keep the kidneys healthy by delivering oxygen
      and nutrients; this delivery of blood to the kidney is called 'perfusion'. We would like to
      perform a research study to test how well a new type of ultrasound scanning (called Contrast
      Enhanced UltraSound or CEUS) can measure kidney perfusion. We will do this by comparing CEUS
      with MRI scans which is the 'gold-standard' method of measuring kidney perfusion. If CEUS
      performs well, then this will allow future studies in which CEUS can be used to help patients
      with kidney disease
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between ASL-MRI and CEUS measures of renal perfusion</measure>
    <time_frame>one week, ideally 1 day.</time_frame>
    <description>The primary outcome will be the correlation between ASL-MRI measures of cortical perfusion (ml/ 100g/min) and CEUS measures of renal microvascular blood flow.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CEUS Repeatability</measure>
    <time_frame>1 day</time_frame>
    <description>Intra-individual reproducibility of the CEUS measures will be assessed by taking at least two measures in each individual to calculate coefficient of variation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between global perfusion from PC-MRI corrected flow measures and CEUS</measure>
    <time_frame>1 week</time_frame>
    <description>Correlation between global perfusion from Phase contrast magnetic resonance Imaging corrected flow measures and CEUS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between kinetic time-intensity parameters of CEUS and time-resolved MRA</measure>
    <time_frame>1 week</time_frame>
    <description>Correlation between kinetic time-intensity parameters of CEUS and time-resolved Magnetic Resonance Angiography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Kidney</condition>
  <condition>Perfusion Imaging</condition>
  <condition>Ultrasonography</condition>
  <arm_group>
    <arm_group_label>young adult</arm_group_label>
    <description>18 - 40 years old (n=10) Healthy male or female and able to give informed, written consent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>older adult</arm_group_label>
    <description>70 years or older (n=10) Healthy male or female and able to give informed, written consent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Contrast enhanced ultrasound</intervention_name>
    <description>This is a regular ultrasound scanner used with an ultrasound contrast agent injected through veins to allow for kidney perfusion acquisition.</description>
    <arm_group_label>older adult</arm_group_label>
    <arm_group_label>young adult</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Arterial Spin Labelling -Magnetic Resonance Imaging</intervention_name>
    <description>Arterial spin labelling is an MRI technique allow for measuring tissue perfusion. It uses magnetically labelled arterial blood water protons as a tracer.</description>
    <arm_group_label>older adult</arm_group_label>
    <arm_group_label>young adult</arm_group_label>
    <other_name>ASL-MRI</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy Volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female aged 18 years or older and able to give informed, written
             consent.

        Exclusion Criteria:

          -  estimated Globular Filtration Rate (eGFR) &lt;60ml/min or albuminuria

               -  Diabetes

               -  Prescription of anti-hypertensive agents that alter renal haemodynamics (renal
                  angiotensin

               -  Known allergy to SonoVue contrast agent

               -  Contraindications to MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nick Selby</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shatha J Almushayt, PhD</last_name>
    <phone>+447575224296</phone>
    <email>mzxsa10@nottingham.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nick Selby</last_name>
    <phone>01332 724665</phone>
    <email>nick.selby@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Nottingham</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Shatha J Almushayt</last_name>
      <phone>07575224296</phone>
      <email>mzxsa10@nottingham.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Odudu A, Nery F, Harteveld AA, Evans RG, Pendse D, Buchanan CE, Francis ST, Fernández-Seara MA. Arterial spin labelling MRI to measure renal perfusion: a systematic review and statement paper. Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii15-ii21. doi: 10.1093/ndt/gfy180.</citation>
    <PMID>30137581</PMID>
  </reference>
  <reference>
    <citation>Liss P, Cox EF, Eckerbom P, Francis ST. Imaging of intrarenal haemodynamics and oxygen metabolism. Clin Exp Pharmacol Physiol. 2013 Feb;40(2):158-67. doi: 10.1111/1440-1681.12042. Review.</citation>
    <PMID>23252679</PMID>
  </reference>
  <reference>
    <citation>Cox EF, Buchanan CE, Bradley CR, Prestwich B, Mahmoud H, Taal M, Selby NM, Francis ST. Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease. Front Physiol. 2017 Sep 14;8:696. doi: 10.3389/fphys.2017.00696. eCollection 2017.</citation>
    <PMID>28959212</PMID>
  </reference>
  <reference>
    <citation>Heinink TP, Read DJ, Mitchell WK, Bhalla A, Lund JN, Phillips BE, Williams JP. Oesophageal Doppler guided optimization of cardiac output does not increase visceral microvascular blood flow in healthy volunteers. Clin Physiol Funct Imaging. 2018 Mar;38(2):213-219. doi: 10.1111/cpf.12401. Epub 2017 Feb 6.</citation>
    <PMID>28168868</PMID>
  </reference>
  <reference>
    <citation>Arthuis CJ, Mendes V, Même S, Même W, Rousselot C, Winer N, Novell A, Perrotin F. Comparative determination of placental perfusion by magnetic resonance imaging and contrast-enhanced ultrasound in a murine model of intrauterine growth restriction. Placenta. 2018 Sep;69:74-81. doi: 10.1016/j.placenta.2018.07.009. Epub 2018 Jul 18.</citation>
    <PMID>30213488</PMID>
  </reference>
  <reference>
    <citation>Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research : an epidemiologic approach. 4th ed ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2013.</citation>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 26, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2019</study_first_posted>
  <last_update_submitted>December 6, 2019</last_update_submitted>
  <last_update_submitted_qc>December 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CEUS</keyword>
  <keyword>MRI</keyword>
  <keyword>kidney perfusion</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

